(MYGN) Myriad Genetics - Performance -77.5% in 12m
MYGN performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-59.62%
#87 in Peer-Group
Rel. Strength
3.56%
#7402 in Stock-Universe
Total Return 12m
-77.51%
#174 in Peer-Group
Total Return 5y
-52.78%
#65 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 476 |
| High / Low | USD |
|---|---|
| 52 Week High | 28.60 USD |
| 52 Week Low | 3.84 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 89.49 |
| Buy/Sell Signal +-5 | -0.51 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: MYGN (-77.5%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: MYGN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MYGN
| Total Return (including Dividends) | MYGN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 5.86% | 3.36% | 5.25% |
| 3 Months | -31.12% | 15.73% | 24.13% |
| 12 Months | -77.51% | -7.02% | 14.15% |
| 5 Years | -52.78% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | MYGN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 44.4% | 4.4% | 81% |
| 3 Months | -51.5% | 78.8% | 96.9% |
| 12 Months | -96.3% | -85.8% | 44.9% |
| 5 Years | -35.1% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th68.00 | 2.42% | 0.58% |
| 3 Month | %th7.00 | -40.48% | -44.51% |
| 12 Month | %th13.50 | -75.81% | -80.30% |
| 5 Years | %th68.00 | -37.70% | -77.71% |
FAQs
Does Myriad Genetics (MYGN) outperform the market?
No,
over the last 12 months MYGN made -77.51%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months MYGN made -31.12%, while XBI made 15.73%.
Performance Comparison MYGN vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
MYGN vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5% | 0.6% | -65% | -92% |
| US NASDAQ 100 | QQQ | 5.2% | 0.6% | -65.7% | -90% |
| German DAX 40 | DAX | 7.1% | 7.3% | -77.2% | -106% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.1% | 2.6% | -68.4% | -97% |
| Hongkong Hang Seng | HSI | 5.4% | -0.2% | -84.5% | -116% |
| India NIFTY 50 | INDA | 6.8% | 2.4% | -65.3% | -77% |
| Brasil Bovespa | EWZ | 2.5% | -3% | -90.1% | -88% |
MYGN vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.3% | -0% | -69.2% | -102% |
| Consumer Discretionary | XLY | 5.5% | 2.7% | -57.4% | -95% |
| Consumer Staples | XLP | 4.7% | 5.2% | -66.7% | -86% |
| Energy | XLE | 4.6% | -1.2% | -60.9% | -77% |
| Financial | XLF | 4.3% | 0.8% | -69.9% | -107% |
| Health Care | XLV | 5.5% | 3.7% | -57.7% | -73% |
| Industrial | XLI | 4.9% | 1.7% | -72.9% | -103% |
| Materials | XLB | 2.7% | 1.6% | -69.5% | -84% |
| Real Estate | XLRE | 5% | 4.9% | -64.7% | -90% |
| Technology | XLK | 4.2% | -2.8% | -67.4% | -89% |
| Utilities | XLU | 6% | 4.1% | -68.3% | -100% |
| Aerospace & Defense | XAR | 7.1% | -1.2% | -83.6% | -127% |
| Biotech | XBI | 4% | 2.5% | -51.8% | -70% |
| Homebuilder | XHB | 2.5% | -1.2% | -57.9% | -83% |
| Retail | XRT | 2.4% | 0.9% | -60.7% | -89% |
MYGN vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 4.1% | -2.58% | -56.6% | -70% |
| Natural Gas | UNG | 14.5% | 15.7% | -48.2% | -75% |
| Gold | GLD | 4.7% | 7.1% | -85.7% | -117% |
| Silver | SLV | 3.9% | -1.1% | -82.4% | -95% |
| Copper | CPER | 5.9% | 1.3% | -82.1% | -88% |
MYGN vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 6.8% | 4.8% | -61.6% | -75% |
| iShares High Yield Corp. Bond | HYG | 6.2% | 4.3% | -63.9% | -88% |